Newmed Energy-limited Partnership, IL0004750209

NewMed Energy stock trades at ILS 15.91, 30.5 percent below 52-week high

Published on 10/09/2026 at 17:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

NewMed Energy stock was at ILS 15.91 on October 9, 2026, versus ILS 22.90 high. Market value was ILS 18.7 billion, with P/E 23.8.

Key points in brief

NewMed Energy stock was last quoted at ILS 15.91 on October 9, 2026, up 0.89 percent versus ILS 15.77.
The price stood 30.5 percent below the 52-week high of ILS 22.90 and 3.7 percent above the low of ILS 15.34.
Market capitalization was ILS 18.7 billion, with a P/E ratio of 23.8 and a dividend yield of 0.04 percent.
TradingView lists November 12, 2026 as the next earnings date.

Newmed Energy-limited Partnership, IL0004750209, Illustration mit AI erstellt.

NewMed Energy-limited Partnership (ISIN IL0004750209) was last quoted at ILS 15.91 on the Tel Aviv Stock Exchange on October 9, 2026 at 12:44 p.m. CEST, up 0.89 percent versus the prior close of ILS 15.77. The price was 30.5 percent below the 52-week high of ILS 22.90 and 3.7 percent above the 52-week low of ILS 15.34.

Yearly range sets the frame

The 52-week range places the stock close to its lower boundary rather than its March peak. The price is ILS 0.57 above the yearly low, while the gap to the high is ILS 6.99, giving the range a clear numerical tilt.

Trading volume reached 934,147 shares on October 9, 2026, against an average volume of 1,036,223 shares. That is 9.85 percent below the average, so the session's turnover was lighter than the recent norm.

Valuation and trading activity

NewMed Energy carried a market capitalization of ILS 18.7 billion as of October 9, 2026. Its P/E ratio was 23.8 and its dividend yield was 0.04 percent, putting the earnings multiple and payout measure at very different scales.

The company's latest reported quarter in the finance statements was the second quarter of 2026. Revenue was USD 250.1 million and net income was USD 110.1 million in that period, compared with USD 163.9 million of revenue and USD 0.1 million of net income in the first quarter of 2026.

Comparison with peers

NewMed Energy-limited Partnership: plus 0.89 percent, P/E 23.8, market capitalization ILS 18.7 billion

Energean plc (LSE, GBp): plus 4.36 percent, P/E minus 8.3, market capitalization GBP 1.3 billion

Delek Group Ltd. (TASE, ILS): minus 0.96 percent, P/E 4.3, market capitalization ILS 14.6 billion

Next report arrives November 12

TradingView lists November 12, 2026 as NewMed Energy's next earnings date. The scheduled report gives the market a defined point for comparing the next quarter with the second-quarter revenue of USD 250.1 million and net income of USD 110.1 million.

Leviathan remains central

NewMed Energy says on its investor relations page that it holds a 45.3 percent working interest in the Leviathan gas field. The company describes its portfolio as spanning production, development and exploration assets, with natural gas supplied mainly across the Mediterranean region.

Price remains below the yearly high

At ILS 15.91, NewMed Energy stood 30.5 percent below its 52-week high and 0.89 percent above the prior close on October 9, 2026. The next scheduled earnings date is November 12, 2026.